Company Filing History:
Years Active: 2001
Title: The Innovations of Valerie A Reader
Introduction
Valerie A Reader is an accomplished inventor based in Princeton, NJ (US). She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target the CCR5 receptor. Her work has implications for treating various diseases, including inflammatory conditions and HIV infection.
Latest Patents
Valerie A Reader holds a patent for "Substituted bis-acridines and related compounds as CCR5 receptor ligands, anti-inflammatory agents and anti-viral agents." This invention focuses on substituted bis-acridines and related compounds that act as ligands, specifically antagonists of the CCR5 receptor. The patent addresses the treatment and prevention of disease states mediated by CCR5, such as asthma, rheumatoid arthritis, and multiple sclerosis. Additionally, since CCR5 is a co-receptor for HIV entry into cells, her invention may also be beneficial in treating HIV infection.
Career Highlights
Valerie has worked with Smithkline Beecham Corporation, where she has been able to apply her expertise in medicinal chemistry. Her innovative approach to drug development has positioned her as a key figure in her field.
Collaborations
Some of her notable coworkers include William Edward Bondinell and Thomas Wen Fu Ku, who have collaborated with her on various projects within the company.
Conclusion
Valerie A Reader's contributions to the field of medicinal chemistry and her innovative patent demonstrate her commitment to advancing healthcare solutions. Her work continues to impact the treatment of significant health issues, showcasing the importance of innovation in medicine.